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POTENTIAL ROLE OF CORONARY PHYSIOLOGY IN TREATING BYSTANDER 
DISEASE IN PATIENTS WITH ST-ELEVATION MYOCARDIAL INFARCTION 
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Robert F. Storey, Julian Gunn 
Dept of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK. 
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Background: Many patients with ST-segment elevation myocardial infarction (STEMI) have non-
culprit lesions (NCLs) in other coronary arteries, for which optimal management is uncertain. In the 
COMPLETE trial, percutaneoƵƐĐŽƌŽŶĂƌǇŝŶƚĞƌǀĞŶƚŝŽŶ ?W/ ?ŽĨĞůŝŐŝďůĞE>Ɛ ?ǀĞƐƐůĚŝĂŵĞƚĞƌA? ? ? ?ŵŵ ?
improved hard clinical outcomes, compared with conservative treatment. However, 99.3% of NCLs 
ǁĞƌĞĂƐƐĞƐƐĞĚďǇǀŝƐƵĂůŝƐĂƚŝŽŶŽĨƚŚĞĂŶŐŝŽŐƌĂŵƵƐŝŶŐĂƚŚƌĞƐŚŽůĚŽĨA? ? ?A?ƐƚĞŶŽƐŝƐ ?ǁŚŝĐŚ is an 
inaccurate method for assessing haemodynamic significance. A pressure wire was used to assess 
ƉŚǇƐŝŽůŽŐŝĐĂůƐŝŐŶŝĨŝĐĂŶĐĞ ?&&ZA? ? ? ? ? ?ŝŶŽŶůǇ ? ? ?A?ŽĨE>ƐƚŚĂƚǀŝƐƵĂůůǇŚĂĚ ? ?-69% stenosis.  
                 
Figure 1: (Left) Angiogram of right coronary artery in a patient with STEMI affecting the left coronary artery. There is a 
proximal bystander lesion in the right coronary artery (arrow). (Right) Using VIRTUheart the bystander lesion is modelled, 
and then computational fluid dynamics are used to compute the virtual FFR. 
Hypothesis: In the real-ǁŽƌůĚ ? ?ƚŚĞƉƌŽƉŽƌƚŝŽŶŽĨ^dD/ƉĂƚŝĞŶƚƐǁŝƚŚE>ƐƚĞŶŽƐĞA? ? ?A?ƚŚĂƚĂƌĞŽĨ
physiological significance, based upon fractional flow reserve (FFR) estimation, is low.  
Methods: The angiograms of consecutive STEMI patients undergoing primary PCI were 
retrospectively reviewed by an interventional cardiologist to identify cases that either had NCL 
ƐƚĞŶŽƐĞƐŽĨ ? ?- ? ?A?ƚŚĂƚǁŽƵůĚŚĂǀĞďĞĞŶĞůŝŐŝďůĞĨŽƌKDW>dŝĨ&&ZǁĂƐA? ? ? ? ?ŽƌĨƵlfilled the 
KDW>dĞůŝŐŝďŝůŝƚǇĐƌŝƚĞƌŝĂďǇǀŝƐƵĂůĂƐƐĞƐƐŵĞŶƚ ?ƐƚĞŶŽƐŝƐA? ? ?A? ? ?dŚĞǀŝƌƚƵĂů&&ZƐŽĨE>ƐǁĞƌĞ
computed using the VIRTUheart tool. The primary outcome was the proportion of all real world 
^dD/ƉĂƚŝĞŶƚƐǁŝƚŚE>ƐƚĞŶŽƐĞƐA? ? ?A? ?^ĞĐŽŶĚĂƌǇŽutcomes were a) the proportion of patients 
ǁŝƚŚE>ƐƚĞŶŽƐĞƐŽĨ ? ?- ? ?A?ǁŚŽŚĂĚǀ&&ZA? ? ? ? ? ? R&&Z-guided PCI group; b) the proportion of NCL 
stenoses of AN ? ?% with ĂǀŝƌƚƵĂů&&ZA? ? ? ? ? ? RW/ǁŝƚŚŽƵƚ&&Z ?ŐƌŽƵƉ ? ? 
Results: ŶŐŝŽŐƌĂŵƐĨƌŽŵ ? ? ?ƉĂƚŝĞŶƚƐƉƌĞƐĞŶƚŝŶg with STEMI and undergoing primary PCI were 
ƌĞǀŝĞǁĞĚ ? ? ?ĐĂƐĞƐ  ? ? ?A? ? ? were found with  ? ?NCLs that would have been potentially suitable for 
inclusion in COMPLETE  ? ? ?A?CI:  ? ? ? ?% to 33.6%) ?KĨƚŚĞƐĞ ? ?ĐĂƐĞƐ ? ? ?A? of NCLs fell into the FFR-
ŐƵŝĚĂŶĐĞ ? ? ? ?-69% stenosis) group ĂŶĚ ? ?A?ŝŶƚŽƚŚĞ RW/ǁŝƚŚŽƵƚ&&Z ? ?A? ? ?A?ƐƚĞŶŽƐŝƐ ?ŐƌŽƵƉ ?KĨƚŚĞ
 ? ? ? ? ?angiograms  ? ? ?A? ?ǁĞƌĞƚĞĐŚŶŝĐĂůůǇƐƵŝƚĂďůĞĨŽƌŵŽĚĞůůŝŶŐ ?ƉŽƐŝƚŝǀĞǀ&&ZǁĂƐĨŽƵŶĚŝŶ ? ?A?ŽĨ
E>Ɛ ? ? ?A?CI P ? ? ? ?A?ƚŽ ? ? ? ?A? ?(see Table  ?). 
 
 
 
Management group 
Haemodynamic significance of NCLs  Total no. 
(%) Y))5 (%) Y))5! (%) 
FFR-guidance for PCI     
PCI without FFR    ( 
Total (%)     
Table 1: Breakdown of haemodynamic significance (vFFR  for NCLs successfully modelled using 
VIRTUheart in each management group, virtual Fractional flow reserve= vFFR, 
 
 
Management group 
Cohort no. (%) 
COMPLETE Sheffield 
FFR-guidance for PCI   
PCI without FFR   
Total     
7DEOHNumber of lesions suitable for pressure wire in COMPLETE and Sheffield populations 
 
Conclusion: In a real-ǁŽƌůĚ ?^dD/ƉŽƉƵůĂƚŝŽŶ ? ? ?A?ŽĨƉĂƚŝĞŶƚƐĐŽƵůĚďĞĐŽŶƐŝĚĞƌĞĚĨŽƌĞŝƚŚĞƌ&&Z
ĂƐƐĞƐƐŵĞŶƚ ?E>ƐƚĞŶŽƐŝƐ ? ?-69%) or PCI without FFR according to the COMPLETE study criteria. 
,ŽǁĞǀĞƌ ?ŽĨƚŚŽƐĞ ?ŶĞĂƌůǇ ? ?A?ƐŚŽƵůĚƵŶĚĞƌŐŽƉŚǇƐŝŽůŽŐŝĐĂůĂƐƐĞƐƐŵĞŶƚ ?ĂĐĐording to COMPLETE 
ĞůŝŐŝďŝůŝƚǇĐƌŝƚĞƌŝĂ ?ĞǀĞŶƚŚŽƵŐŚǀĞƌǇĨĞǁǁĞƌĞĂĐƚƵĂůůǇĞŶƌŽůůĞĚŽŶƚŚŝƐďĂƐŝƐ ?KĨƚŚĞ ? ?A? ?ŽŶůǇ ? ?A?
ǁĞƌĞƉŚǇƐŝŽůŽŐŝĐĂůůǇƐŝŐŶŝĨŝĐĂŶƚ ?ĂŶĚ ?ŽĨĂůůƚŚĞE>Ɛ ?ŽŶůǇ ? ?A?ǁĞƌĞƉŚǇƐŝŽůŽŐŝĐĂůůǇƐŝŐŶŝĨŝĐĂŶƚ ?
Further work is required to determine whether virtual FFR might provide a cost-effective means of 
identifying patients who will benefit from NCL revascularisation.   
 
